Induction therapy (IT) with paclitaxel (P) and CBDCA (C) followed by hyperfractionated radiotherapy (HFR) + weekly concurrent chemotherapy (WT) and subsequent manteinance therapy in unresectable NSCLC (Stage IIIA N2 bulky, Stage IIIB)

✍ Scribed by Moscetti, L; Cortesi, E; Ramponi, S; Corona, M; Donato, V; De Marinis, F; Ammaturo, M.V; De Paula, U

• Book ID: 118569625
• Publisher: Elsevier Science
• Year: 2000
• Tongue: English
• Weight: 117 KB
• Volume: 29
• Category: Article
• ISSN: 0169-5002
• DOI: 10.1016/s0169-5002(00)80080-x